This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gesellschaft MIT Beschraenkter Haftung. Active years: 1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980
Title: Giuliano Dolce: Innovator in Central Nervous System Depressants
Introduction
Giuliano Dolce is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of central nervous system depressants. His innovative work has led to the creation of a unique patent that showcases his expertise in medicinal chemistry.
Latest Patents
Giuliano Dolce holds a patent for "3-Fluorobenzodiazepines - 3-Fluoro-2,3-dihydro-1H-1,4-benzodiazepin-2-ones." This patent describes compounds of the formula wherein R.sup.1 is H, alkyl or fluorinated alkyl of 1-4 carbon atoms and up to 9 fluorine atoms or cycloalkylalkyl of 4-8 carbon atoms; R.sup.2 is phenyl; monohalophenyl or pyridyl; R.sup.3 is F, Cl, Br or NO.sub.2, and physiologically acceptable acid addition salts thereof. These compounds are recognized for their potential as central nervous system depressants, highlighting the importance of his research in this area.
Career Highlights
Giuliano Dolce is associated with Merck Patent Gesellschaft mit beschränkter Haftung, a prominent company in the pharmaceutical industry. His work at Merck has allowed him to focus on innovative drug development, contributing to advancements in therapeutic options for patients.
Collaborations
Throughout his career, Giuliano has collaborated with esteemed colleagues such as Eike Poetsch and Jurgen Uhl. These collaborations have fostered a productive environment for research and development, enhancing the quality and impact of their work.
Conclusion
Giuliano Dolce's contributions to the field of pharmaceuticals, particularly through his patent on central nervous system depressants, demonstrate his innovative spirit and dedication to advancing medical science. His work continues to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile